Virtual Forum: Treatment Of Schizophrenia: Focus On Psychopharmacology & Adherence
Location: Online Via PsychU.org
Description: While treating to remission is the goal in schizophrenia, it remains a target not achieved for many patients. In this virtual forum, Henry A. Nasrallah, MD and Roger Sommi, PharmD, BCPP, FCCP will discuss several considerations in optimizing the treatment of patients with schizophrenia. The speakers will explore the consequences of relapse for patients with schizophrenia who discontinue medications, will discuss patient- and system-level indicators that may aid in the identification of those patients at a high potential for discontinuing antipsychotic therapy, and will address how physicians can use basic pharmacogenomics to guide dosing of antipsychotics. The virtual forum will conclude with time for questions from the audience.
Speakers are paid consultants for Otsuka Pharmaceutical Development & Commercialization, Inc.View Flyer (PDF)
Not a member? Sign up for free!
Join us as we continue our efforts towards improving the future of mental health care through information, discussion, and collaboration.
Sign up today for instant access to all PsychU offerings. Membership is free!